Breaking News Instant updates and real-time market news.

ADI

Analog Devices

$78.66

1.67 (2.17%)

, JBLU

JetBlue

$21.39

0.19 (0.90%)

09:41
04/21/17
04/21
09:41
04/21/17
09:41

Unusually active option classes on open April 21st

Unusual total active option classes on open include: Analog Devices (ADI), JetBlue (JBLU), Expedia (EXPE), Kohl's (KSS), Yelp (YELP), Schlumberger (SLB), Market Vectors Oil Services (OIH), General Electric (GE), SPDR Gold Trust (GLD), and iShares Silver Trust (SLV).

ADI

Analog Devices

$78.66

1.67 (2.17%)

JBLU

JetBlue

$21.39

0.19 (0.90%)

EXPE

Expedia

$131.93

0.98 (0.75%)

KSS

Kohl's

YELP

Yelp

SLB

Schlumberger

OIH

Oil Services Holders Trust

GE

General Electric

GLD

SPDR Gold Trust

SLV

iShares Silver Trust

  • 21

    Apr

  • 21

    Apr

  • 25

    Apr

  • 26

    Apr

  • 27

    Apr

  • 01

    May

  • 01

    May

  • 09

    May

  • 16

    May

  • 31

    May

  • 05

    Jun

  • 08

    Jun

  • 20

    Jun

  • 22

    Jun

ADI Analog Devices
$78.66

1.67 (2.17%)

02/16/17
LYON
02/16/17
NO CHANGE
LYON
Analog Devices results 'solid,' says CLSA
CLSA analyst Chris Caso believes that Analog Devices reported "solid" results and provided conservative guidance. The analyst thinks that the company's EPS can reach $5, as he believes that the company's core markets are "strong." Caso raised his price target on the shares to $92 from $85 and reiterates an Outperform rating on the stock.
02/16/17
BARD
02/16/17
NO CHANGE
Target $86
BARD
Outperform
Analog Devices price target raised to $86 from $77 at Baird
Baird analyst Tristan Gerra raised his price target on Analog Devices to $86 from $77 following better than expected Q1 results. The analyst cited continued momentum in end-demand trends, linear tech accretion, and gross margin leverage. Gerra reiterated his Outperform rating on Analog Devices shares.
03/14/17
FBCO
03/14/17
INITIATION
Target $100
FBCO
Outperform
Analog Devices reinitiated with an Outperform at Credit Suisse
Credit Suisse analyst John Pitzer reinstated coverage of Analog Devices (ADI) with an Outperform rating and a $100 price target, saying the recently completed merger with Linear Technology (LLTC) creates the second largest analog company.
03/20/17
JEFF
03/20/17
NO CHANGE
Target $100
JEFF
Buy
Analog Devices price target raised to $100 from $94 at Jefferies
Jefferies analyst Mark Lipacis raised his price target for Analog Devices to $100 to account for the acquisition of Linear Technology. The analyst likes Analog's free cash flow growth prospects and keeps a Buy rating on the shares.
JBLU JetBlue
$21.39

0.19 (0.90%)

01/27/17
01/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Whirlpool (WHR) downgraded to Neutral from Buy at Goldman with analyst Samuel Eisner saying "tough" pricing in North America and "stronger" raw material headwinds should limit margin expansion. The analyst sees some risk to Whirlpool's 2017 guidance, especially in the back half of the year, and cut his price target for the shares to $187 from $191. 2. JetBlue (JBLU) was downgraded to Hold from Buy at Argus and to Underperform from Peer Perform at Wolfe Research. 3. Weatherford (WFT) downgraded to Hold from Buy at Jefferies with analyst Brad Handler citing a challenging international landscape, "disappointing" free cash flow in 2016 and continued share dilution. The analyst lowered his price target for the shares to $6 from $7. 4. Graphic Packaging (GPK) downgraded to Buy from Conviction Buy at Goldman with analyst Brian Maguire saying shares have underperformed since the guidance cut in October due to weaker end markets, higher OCC costs, foreign exchange, inventory restocking, Hurricane Mathew, and inventory restocking. 5. 8point3 Energy (CAFD) was downgraded to Underperform from Market Perform at Avondale and to Neutral from Buy at Roth Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/27/17
WOLF
01/27/17
DOWNGRADE
WOLF
Underperform
JetBlue downgraded to Underperform from Peer Perform at Wolfe Research
01/27/17
ARGS
01/27/17
DOWNGRADE
ARGS
Hold
JetBlue downgraded to Hold from Buy at Argus
Argus analyst David Coleman downgraded JetBlue to Hold due to valuation and rising costs. The analyst said shares have had a strong run over the past five years but fuels costs and other expenses are rising, and is less bullish on the earnings outlook.
01/25/17
JPMS
01/25/17
DOWNGRADE
Target $55
JPMS
Neutral
Southwest downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jamie Baker downgraded Southwest Airlines (LUV) to Neutral saying the shares look less attractive at $50. The analyst recommends swapping into JetBlue (JBLU), a stock he upgraded this morning to Overweight. Baker raised his price target for Southwest shares to $55 from $51.50.
EXPE Expedia
$131.93

0.98 (0.75%)

03/03/17
03/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Expedia (EXPE) upgraded to Neutral from Sell at Citi with analyst Mark May citing greater comfort in the growth of the company's hotel business. The analyst, who noted that recently disclosed room night and bookings growth at HomeAway gives him a more bullish view on its long-term growth, raised his price target on Expedia shares to $130 from $116. 2. Helmerich & Payne (HP) upgraded to Outperform from Market Perform at Bernstein with analyst Colin Davies citing higher U.S. rig demand and valuation. Target to $84 from $86. 3. Dr Pepper Snapple (DPS) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy saying that its recently-acquired Bai brand is an underappreciated growth platform for the company. He expects Bai to contribute 2-3 points to Dr Pepper's core sales growth over the next 3-5 years and increased his 2017-18 organic sales and EPS forecasts. Grundy increased his price target on Dr Pepper shares to $115 from $98. 4. KeyCorp (KEY) upgraded to Outperform from Hold at Evercore ISI. 5. Southern Company (SO) upgraded to Buy from Hold at Jefferies with analyst Anthony Crowdell saying he thinks the company will be able to deliver on its 5% earnings per share growth target given all the levers available to pull. He also believes investors are pricing in a Kemper scenario that is worse than worst-case and sees the Vogtle nuclear project is less of a concern than is factored in at current levels, Crowdell tells investors. He raised his price target on Southern Company shares to $56 from $50. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/17
MACQ
03/06/17
UPGRADE
Target $144
MACQ
Outperform
Expedia upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Tom White upgraded Expedia to Outperform and raised its price target to $144 from $123 on re-accelerating core growth and reset investor expectations for HomeAway. White said Expedia is making needed investments to realize the long-term monetization potential of HomeAway (AWAY) views valuation as reasonable.
03/06/17
03/06/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Buy from Neutral at UBS with analyst Doug Mitchelson saying momentum in Europe and Latin American, coupled with modest improvements in Japan, should drive upside to the first quarter subscriber guidance. Further, the analyst says Netflix's leadership positions in the U.S., U.K. and Canada "appear secure." The analyst expects Q1 international net additions of 4.1M versus Netflix's guidance and consensus of 3.7M. Mitchelson believes concerns regarding competition and content costs are misplaced. 2. FedEx (FDX) upgraded to Outperform from Market Perform at BMO Capital with analyst Fadi Chamoun saying the company should benefit from the improved outlook for the U.S. industrial sector and from the bottoming of the operating margins of its ground business. Chamoun adds that the company's capital spending should "moderate in coming years," while its valuation provides "a margin of safety." 3. Expedia (EXPE) upgraded to Outperform from Neutral at Macquarie with analyst Tom White citing re-accelerating core growth and reset investor expectations for HomeAway. White said Expedia is making needed investments to realize the long-term monetization potential of HomeAway (AWAY) views valuation as reasonable. 4. Garmin (GRMN) upgraded to Neutral from Sell at Goldman with analyst Simona Jankowski saying the risk/reward is balanced following the recent underperformance. The analyst no longer sees downside to consensus estimates, and expects a return to growth in 2018. Jankowski raised her price target for Garmin shares to $52 from $48. 5. Alcoa (AA) upgraded to Buy from Neutral at Goldman with analyst Andrew Quail saying China's capacity cuts are improving industry dynamics. Quail expects Alcoa to generate a 12% free cash yield on average through 2018 amid higher aluminum and alumina prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/07/17
COWN
04/07/17
NO CHANGE
COWN
Cowen travel agent survey positive for Sabre, Travelport and Expedia
Cowen conducted a travel agent survey to gauge trends on sentiment, demand for airline products, dynamics in the Global Distribution System marketplace, and participation in online travel affiliate programs. The agents skewed bullish overall and the survey was positive for Sabre (SABR), Travelport (TVPT), and Expedia (EXPE), the firm reported. The survey showed meaningful demand for economy products, controlled GDS incentive payment growth, and a majority of respondents said selling ancillary airline services is not financially worthwhile for them, Cowen's analysts noted.
KSS Kohl's

04/03/17
PIPR
04/03/17
NO CHANGE
Target $38
PIPR
Overweight
Piper says Nike still outselling Under Armour at Kohl's
Piper Jaffray analyst Erinn Murphy says her store checks indicate Nike (NKE) is still outselling Under Armour (UA, UAA) at Kohl's (KSS), a month into Under Armour's launch at the retailer. Under Armour started promoting items two weeks ago, and while men's and kids are performing, women's is underperforming, Murphy tells investors in a research note. She believes the "pressure is on" after learning that Kohl's stores are in competition with each other to sell the most Under Armour products by the end of the month. Murphy has concerns about Under Armou's ability to drive sales as Kohls's. She lowered her Q1 estimates for Kohl's, dropped her price target for the shares to $38 from $39 and keeps a Neutral rating on the name.
03/21/17
CLVD
03/21/17
NO CHANGE
CLVD
Kohl's Q1 comps trending below consensus, says Cleveland Research
04/03/17
FBRC
04/03/17
DOWNGRADE
Target $14
FBRC
Underperform
Under Armour downgraded to Underperform from Market Perform at FBR Capital
FBR Capital analyst Susan Anderson downgraded Under Armour (UAA) to Underperform and cut her price target for the shares to $14 from $20. The analyst's recent channel checks and proprietary survey point to continued sales and margin pressure. Further, the checks show a price war is intensifying between Nike (NKE) and Under Armour following the latter's entrance into Kohl's (KSS). She believes Under Armour's apparel growth and margins may be worse than expected.
04/19/17
DBAB
04/19/17
NO CHANGE
Target $17
DBAB
Hold
Under Armour Q1 sales may have slowed more than guidance, says Deutsche Bank
Deutsche Bank analyst Paul Trussell says his channel checks throughout Q1 have been mixed for Under Armour. Solid sell-through at recently launched Kohl's (KSS) and ongoing favorable trends at Dick's Sporting Goods (DKS) was offset by a weaker DTC effort and wholesale challenges in footwear, Trussell tells investors in a research note. He believes Under Armour's Q1 sales may have decelerated more than guidance provided on January 31. The analyst sees risk to the FY17 outlook but adds that a guidance cut may not happen with this earnings report. Trussell keeps a Hold rating on Under Armour with a $17 price target.
YELP Yelp

04/11/17
04/11/17
UPGRADE
Target $43

Overweight
Yelp upgraded to Overweight on 'underappreciated core' at Pacific Crest
As previously reported, Pacific Crest analyst Brad Erickson upgraded Yelp (YELP) to Overweight from Sector Weight, saying his checks with local ad customers indicate Yelp's core franchise is healthy and appears insulated from larger competitors like Google (GOOG) and Facebook (FB). Over $60B of offline local ad spending is shifting toward online and Yelp remains well-positioned to capitalize on this trend, though its core business is underappreciated in the shares' current value, said Erickson, who has a $43 price target on the stock.
04/11/17
04/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Conviction Buy from Buy at Goldman with analyst Drew Borst saying that the success of "Beauty and the Beast" has increased his confidence in his forecast that FY18 EPS growth will accelerate given the company's promising film slate and its read-through to consumer products. He also sees accelerating profit growth at ESPN given normalizing NBA costs and predicts record results for the Theme Parks segment. Borst keeps a $138 price target on Disney shares. 2. McDonald's (MCD) upgraded to Buy from Neutral at Cleveland Research. 3. Yelp (YELP) upgraded to Overweight from Sector Weight at Pacific Crest with analyst Brad Erickson saying his checks with local ad customers indicate Yelp's core franchise is healthy and appears insulated from larger competitors like Google (GOOG, GOOGL) and Facebook (FB). 4. Toll Brothers (TOL) upgraded to Outperform from Sector Perform at RBC Capital with analyst Robert Wetenhall citing "solid demand,strong execution, proven management, a strong luxury housing business, and consistent earnings." 5. Sanofi (SNY) upgraded to Neutral from Underweight at JPMorgan with analyst Richard Vosser saying he no longer sees downside to consensus estimates. The pressure on the diabetes business now seems largely reflected in estimates, Vosser tells investors in a research note. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/13/17
DBAB
04/13/17
NO CHANGE
Target $52
DBAB
Buy
Negative sentiment on Yelp overblown, says Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley said negative sentiment on Yelp has been overblown and he expects Local Advertising Account additions to perform better in Q1. Improving self-serve infrastructure can drive higher ARPU and allow the company room to spend more on marketing, added Walmsley, who sees "the bar here as low for Yelp" ahead of the company's upcoming earnings report. He keeps a Buy rating and $52 price target on Yelp shares.
04/11/17
PACS
04/11/17
UPGRADE
Target $43
PACS
Overweight
Yelp upgraded to Overweight from Sector Weight at Pacific Crest
Pacific Crest analyst Brad Erickson upgraded Yelp to Overweight with a $43 price target.
SLB Schlumberger

04/19/17
04/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. ING Group (ING) initiated with a Buy at Jefferies. 2. T-Mobile (TMUS) was initiated with a Buy at SunTrust while Sprint (S), Verizon (VZ), and AT&T (T) were initiated with a Hold. 3. DXC Technology (DXC) initiated with an Overweight at JPMorgan. 4. LendingClub (LC) coverage resumed with a Hold at Stifel. 5. Halliburton (HAL) and Schlumberger (SLB) were initiated with a Buy at HSBC while Baker Hughes (BHI) was initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/19/17
HSBC
04/19/17
INITIATION
Target $90
HSBC
Buy
Schlumberger initiated with a Buy at HSBC
HSBC analyst David Phillips initiated Schlumberger with a Buy and a $90 price target saying strong operating performance is expected to continue and is well positioned given the structural changes within its organization through its transformation and technology plans.
03/27/17
RHCO
03/27/17
NO CHANGE
RHCO
Schlumberger, Weatherford to benefit from deal, says SunTrust
After Weatherford (WFT) and Schlumberger (SLB) combined their North American completions assets into a joint venture, SunTrust analyst Ken Sill says the deal enables Schlumberger to enhance its underdeveloped U.S. pressure pumping operations, while providing Weatherford with $535M in cash that it can use to reduce its debt. The analyst expects the deal to be accretive for both companies. He keeps a Buy rating on Weatherford and a Hold rating on Schlumberger.
03/27/17
BMOC
03/27/17
NO CHANGE
BMOC
Deal worth up to $2.6B for Weatherford, says BMO Capital
After Weatherford (WFT) and Schlumberger (SLB) combined their North American completions assets into a joint venture, BMO Capital analyst Daniel Boyd estimates that the deal is worth $1.7B-$2.6B to Weatherford. The analyst says that Schlumberger benefits because the deal increases its exposure to North America while costing little capital.
OIH Oil Services Holders Trust

GE General Electric

04/10/17
FBRC
04/10/17
NO CHANGE
FBRC
FBR views Tesco as most likely takeover in Oilfield Services
FBR Capital analyst Thomas Curran says that within his Oilfield Services coverage, Tesco (TESO) has the highest probability of a straight acquisition. In GE Oil & Gas (GE) and Forum Energy (FET), Tesco has at least two potential strategic acquirers with "highly compelling logic," Curran tells investors in a research note. He believes a buyer could offer $10 per share. Tesco closed Friday at $7.30.
03/31/17
WBLR
03/31/17
NO CHANGE
WBLR
Outperform
General Electric shares set to move higher, says William Blair
William Blair analyst Nicholas Heymann believes shares of General Electric are set to move higher, not on management changes, but stronger fundamentals as the "external macro environment continues to improve." If GE achieves its more aggressive 2017 fundamental performance hurdles, the shares should be set to move steadily higher to the mid- to upper $30s, Heymann tells investors in a research note. The analyst sees potential upside to estimates from U.S. corporate tax reform and U.S. privately financed infrastructure modernization. He keeps an Outperform rating on GE shares.
03/28/17
JPMS
03/28/17
NO CHANGE
Target $27
JPMS
Underweight
General Electric price target lowered to $27 from $29 at JPMorgan
JPMorgan analyst C. Stephen Tusa lowered his price target for General Electric to $27 and keeps an Underweight rating on the shares. The sell-side bull thesis is shifting focus away from the $2.00 earnings per share target in 2018 to free cash flow, which is "seemingly appropriately," Tusa tells investors in a research note. The analyst views the emerging bull case on free cash flow as "overstated and not plausible." He notes his new $27 price target still implies a premium 4% free cash yield and "solid" 3.5% dividend yield.
03/13/17
JPMS
03/13/17
NO CHANGE
Target $29
JPMS
Underweight
JPMorgan says use GE rally as selling opportunity
JPMorgan analyst C. Stephen Tusa recommends using Friday's rally in General Electric shares as a selling opportunity. A possible CEO change does not change the analyst's view that GE is an expensive stock. Discussion of an activist, who owns less than 1% of the company, trying to make changes is a re-run of the case made two years ago, Tusa tells investors in a research note. The analyst does not see much a GE activist can do. The company's "stubbornly low growth and secular challenges embedded in end markets" can't be fixed by a CEO, the analyst contends. Tusa keeps an Underweight rating on shares of GE with a $29 price target. The stock rallied Friday to $30.28 after Fox Business reported that CEO Jeff Immelt is on the "hot seat" with activist Nelson Peltz.
GLD SPDR Gold Trust

SLV iShares Silver Trust

TODAY'S FREE FLY STORIES

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

HIMX

Himax

$8.17

-0.02 (-0.24%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
Himax management to meet with Roth Captial »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

ANTM

Anthem

$190.17

-3.19 (-1.65%)

18:58
06/23/17
06/23
18:58
06/23/17
18:58
Periodicals
Anthem to pay $115M to settle data breach lawsuits, Reuters reports »

Anthem has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVU

Supervalu

$2.94

-0.04 (-1.34%)

18:26
06/23/17
06/23
18:26
06/23/17
18:26
Hot Stocks
Supervalu completes acquisition of Unified Grocers »

Supervalu announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$70.52

0.04 (0.06%)

18:14
06/23/17
06/23
18:14
06/23/17
18:14
Periodicals
Gilead no longer a 'value trap,' Barron's reports »

Consistent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

, EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

18:07
06/23/17
06/23
18:07
06/23/17
18:07
Hot Stocks
Southern National Bancorp, Eastern Virginia Bankshares complete merger »

Southern National Bancorp…

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAC

IAC

$104.84

0.3 (0.29%)

17:56
06/23/17
06/23
17:56
06/23/17
17:56
Hot Stocks
IAC will not pursue plan to create new class of non-voting stock »

IAC's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

EGL

Engility

$27.37

0.26 (0.96%)

17:50
06/23/17
06/23
17:50
06/23/17
17:50
Hot Stocks
Engility to eliminate position of president, COO »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

ADM

Archer Daniels

$41.16

0.13 (0.32%)

17:48
06/23/17
06/23
17:48
06/23/17
17:48
Hot Stocks
ADM Animal Nutrition recalls Rough-N-Ready cattle feed over monensin concerns »

ADM Animal Nutrition, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOYA

Voya Financial

$35.24

0.03 (0.09%)

17:30
06/23/17
06/23
17:30
06/23/17
17:30
Syndicate
Breaking Syndicate news story on Voya Financial »

Voya Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

, TBK

Triumph Bancorp

17:19
06/23/17
06/23
17:19
06/23/17
17:19
Hot Stocks
Independent Bank to sell nine Colorado branches to TBK Bank »

Independent Bank (IBTX)…

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

TBK

Triumph Bancorp

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

WUBA

58.com

$43.30

0.87 (2.05%)

17:11
06/23/17
06/23
17:11
06/23/17
17:11
Hot Stocks
Breaking Hot Stocks news story on 58.com »

General Atlantic reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

, LGF.B

Lionsgate

$25.38

0.34 (1.36%)

17:10
06/23/17
06/23
17:10
06/23/17
17:10
Hot Stocks
Box Office Battle: 'Transformers' expected to top 'Cars 3,' 'Wonder Woman' »

Viacom (VIA, VIAB)…

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

LGF.B

Lionsgate

$25.38

0.34 (1.36%)

DIS

Disney

$104.36

0.14 (0.13%)

VIAB

Viacom

$34.11

-0.01 (-0.03%)

LGF.A

Lionsgate

$27.07

0.31 (1.16%)

VIA

Viacom

$39.15

0.1 (0.26%)

SNE

Sony

$38.52

0.11 (0.29%)

FOX

21st Century Fox

$26.93

0.3 (1.13%)

TWX

Time Warner

$99.70

0.3 (0.30%)

CMCSA

Comcast

$39.50

-0.44 (-1.10%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

  • 03

    Aug

  • 08

    Aug

NVUS

Novus Therapeutics

$6.00

-0.04 (-0.66%)

17:07
06/23/17
06/23
17:07
06/23/17
17:07
Syndicate
Breaking Syndicate news story on Novus Therapeutics  »

Novus Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXG

Interpace Diagnostics

$0.88

0.03 (3.53%)

17:05
06/23/17
06/23
17:05
06/23/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Interpace Diagnostics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$14.95

0.26 (1.77%)

17:02
06/23/17
06/23
17:02
06/23/17
17:02
Hot Stocks
Monmouth Real Estate acquires building in Texas for $50.6M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

ARCW

ARC Group

$3.55

0.15 (4.41%)

17:01
06/23/17
06/23
17:01
06/23/17
17:01
Hot Stocks
ARC Group names Drew Kelley as Interim CEO, effective July 1 »

ARC Group Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAVM

PAVmed

$4.41

-0.08 (-1.78%)

16:55
06/23/17
06/23
16:55
06/23/17
16:55
Syndicate
PAVmed announces effectiveness of Form S-1 resale registration statement »

PAVmed announced that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFSF

MutualFirst Financial

$36.15

0.9 (2.55%)

16:48
06/23/17
06/23
16:48
06/23/17
16:48
Hot Stocks
MutualFirst Financial senior executives enter 10b5-1 trading plans »

On June 23, David Heeter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.10

0.25 (0.78%)

16:46
06/23/17
06/23
16:46
06/23/17
16:46
Hot Stocks
Cisco CEO Charles Robbins enters 10b5-1 trading plan »

On June 21, Charles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 16

    Aug

SITO

SITO Mobile

$3.66

0.02 (0.55%)

16:43
06/23/17
06/23
16:43
06/23/17
16:43
Hot Stocks
SITO Mobile chairman Paul Pressler resigns »

Effective as of June 23,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$517.33

-9.2 (-1.75%)

, CELG

Celgene

$134.31

0.63 (0.47%)

16:41
06/23/17
06/23
16:41
06/23/17
16:41
General news
S&P sees mild weekly gain, Nasdaq outperforms as biotech shines »

The S&P finished the…

REGN

Regeneron

$517.33

-9.2 (-1.75%)

CELG

Celgene

$134.31

0.63 (0.47%)

GILD

Gilead

$70.54

0.06 (0.09%)

BIIB

Biogen

$280.32

-0.25 (-0.09%)

VRTX

Vertex

$133.50

-2.03 (-1.50%)

AMGN

Amgen

$172.50

-1.32 (-0.76%)

ABBV

AbbVie

$72.64

-0.54 (-0.74%)

ALXN

Alexion

$126.07

-0.16 (-0.13%)

BA

Boeing

$202.23

2.79 (1.40%)

ORCL

Oracle

$50.95

0.65 (1.29%)

EQT

EQT Corporation

$56.19

4.16 (8.00%)

RICE

Rice Energy

$25.65

1.62 (6.74%)

SYK

Stryker

$141.12

-0.1 (-0.07%)

NVDQ

Novadaq

$11.78

-0.02 (-0.17%)

PRXL

Parexel

$86.80

-0.31 (-0.36%)

LH

LabCorp

$151.62

1.28 (0.85%)

ICLR

ICON plc

$96.37

-0.26 (-0.27%)

NKE

Nike

$52.85

0.45 (0.86%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

INTC

Intel

$34.19

-0.17 (-0.49%)

AMD

AMD

$14.15

-0.23 (-1.60%)

LZB

La-Z-Boy

$32.30

0.7 (2.22%)

RHT

Red Hat

$99.42

0.54 (0.55%)

AAL

American Airlines

$48.63

-0.34 (-0.69%)

HCA

HCA Holdings

$86.24

0.1 (0.12%)

LPNT

LifePoint

$65.50

-1.6 (-2.38%)

THC

Tenet

$18.52

-0.38 (-2.01%)

SCS

Steelcase

$13.65

-0.45 (-3.19%)

ACN

Accenture

$122.74

0.66 (0.54%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 07

    Jul

  • 13

    Jul

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 14

    Aug

  • 29

    Aug

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 23

    Oct

  • 14

    Nov

  • 15

    Jan

  • 03

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

16:39
06/23/17
06/23
16:39
06/23/17
16:39
General news
Moody's raises Greece rating to Caa2 from Caa3, outlook to positive from stable »

Moody's has upgraded…

CFCO

CF Corporation

$11.42

-0.04 (-0.35%)

16:38
06/23/17
06/23
16:38
06/23/17
16:38
Hot Stocks
Breaking Hot Stocks news story on CF Corporation »

Mason Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.65

0.35 (5.56%)

, X

U.S. Steel

$22.25

1.18 (5.60%)

16:34
06/23/17
06/23
16:34
06/23/17
16:34
General news
On The Fly: Top stock stories for Friday »

Stocks opened in quiet…

AKS

AK Steel

$6.65

0.35 (5.56%)

X

U.S. Steel

$22.25

1.18 (5.60%)

PTLA

Portola Pharmaceuticals

$56.13

17.88 (46.75%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

SNCR

Synchronoss

$16.24

4.06 (33.33%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 23

    Jun

  • 24

    Jun

  • 26

    Jun

  • 29

    Jun

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 15

    Jan

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.